Light AI

Light AI holds a Health Canada medical-device licence for its pharyngitis-screening software. It has publicly disclosed filing a 510(k) premarket notification with the U.S. Food and Drug Administration for the same indication, but FDA clearance has not yet been granted as of the firm's most recent securities filings.

A clinician captures an image of the patient's pharynx using a standard smartphone camera. The software analyzes the image with a convolutional neural network trained on a curated dataset of positive and negative strep cases, returning a binary result — 'positive' or 'negative' for Group A Streptococcus — without requiring a throat-swab cartridge or external hardware.

Neither. Light AI is a publicly listed healthcare-technology company traded on the TSX Venture Exchange. It develops and commercializes its own diagnostic software rather than allocating capital to third-party funds or operating as a family investment vehicle.

Light AI has not named an external chief medical officer or regulatory lead in its public filings to date. Responsibility for clinical validation and FDA interaction is held internally by the executive team, whose backgrounds include medical-device commercialization and machine-learning research.

The foundational intellectual property originated in research settings linked to UBC-affiliated clinicians who contributed the initial throat-image dataset. The firm's lead scientist and certain board members have held academic appointments there, but the university does not hold an equity stake disclosed above the reporting threshold.